1Colquitt JL, Green C, Sidhu MK, et al. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes, Health Technology Assessment 2004;8:43.
2Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003; 26:1079 - 1087.
3Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials, BMJ 2002; 324: 705.
4Pickup J, Keen H. Continuous subcutaneous insulin infusion at25 Years, Diabetes Care 2002 ;25: 593 - 598.
5Plotnick LP, Clark LM, Brancat FL, et al. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003; 26:1142 - 1146.
6Hanas R. Selection for and initiat ion of continuous subcutaneous insulin infusion. Horm Res 2002;57(suppl 1):101- 104.
7Simmons D, Thompson CF, Conroy C, et al. Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community, Diabetes Care 2001; 24:2078 -2082.
8Steel JM, Johnstone FD, Hume R, et al. Insulin requirements during pregnancy in women with type 1 diabetes. Obstet Gynecol1994; 83: 253 - 258.
